Skip to main content

Table 2 Multivariate Cox Proportional Hazard Model of Associated Factors with Cancer Mortality

From: Social isolation, inflammation, and cancer mortality from the National Health and Nutrition Examination Survey - a study of 3,360 women

Characteristics

Hazard Ratio

95% Confidence Interval

P-value

Social Network Index

 4 = Not isolated

1

  

 3 = Somewhat isolated

0.72

0.41–1.27

0.25

 2 = Very isolated

0.81

0.39–1.70

0.58

 0/1 = Most isolated

0.76

0.28–2.06

0.58

Race/Ethnicity

 White

1

  

 Black

1.35

0.84–2.17

0.22

 Mexican American

1.13

0.70–1.82

0.62

 Othera

1.04

0.22–4.82

0.96

Income Level

 Low income

1

  

 Middle income

0.89

0.57–1.38

0.60

 High income

0.98

0.60–1.60

0.94

Education

 Fewer than 12 years

1

  

 12 years or more

1.36

1.01–1.83

0.04

BMI (kg/m2)

  < 30.0 kg/m2

1

  

  ≥ 30.0 kg/m2

1.56

1.11–2.18

0.01

Diabetes Diagnosis

 No

1

  

 Yes

0.72

0.33–1.55

0.39

Cardiovascular Disease Diagnosis

 No

1

  

 Yes

0.78

0.49–1.24

0.29

Smoking Status

 Nonsmoker

1

  

 Former

2.07

1.15–3.73

0.02

 Current

4.42

2.84–6.88

< 0.001

Alcohol Consumption

 Nondrinker

1

  

 Former

1.15

0.72–1.83

0.56

 Current

0.96

0.57–1.65

0.89

Relative Physical Activity

 About the same

1

  

 Less active

1.57

1.10–2.26

0.01

 Most active

0.67

0.51–0.87

0.004

Self-reported Health Status

 Excellent

1

  

 Very good

1.47

0.98–2.20

0.06

 Good

1.37

0.97–1.94

0.07

 Fair

1.05

0.62–1.77

0.85

 Poor

0.41

0.14–1.19

0.10

Non-Steroidal Anti-Inflammatory Drug Use

 Nonuserb

1

  

 User

1.13

0.79–1.60

0.49

C-Reactive Protein (mg/dL)

  ≤ 0.21 mg/dL

1

  

 0.22–0.63 mg/dL

1.19

0.80–1.77

0.37

  > 0.63 mg/dL

0.88

0.53–1.45

0.60

Fibrinogen (mg/dL)

1.001

1.00–1.003

0.49

  1. a Other race consists of mixed race, Asians, and any other race not specified in the NHANES III database
  2. b Non-steroidal anti-inflammatory drugs (NSAID) nonuser includes those who never taken NSAID and never taken NSAID on a regular basis (< 30 pills/month)